Duramed (DRMD) Synthetic Estrogen Product Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: darbyred who wrote (1816)	6/30/2001 8:49:54 PM
From: vestor	Read Replies (1) of 1837

I agree and am very disappointed given the facts known to me. However I am hearing that it is as good as a done deal. Solvays votes account for 5 % and I tend to think they OK'd the sale. I cannot see AHP coming into the picture and doubt there will be a friendly/hostile offer made. If DRMD shareholders held in total perhaps there is an outside chance the deal would be voted down but I sense many have expressed their disatisfaction by selling. Assuming I am correct the next thing to do is to judge the investment desirability of owning BRL. With an anticipated Aug. go ahead for their generic version of Prozac with 6 month exclusivity and the cash to promote the Cenestin menu I think being a BRL shareholder is not unwise. The current PE is well below industry standard and generic Prozac could add $4. share earnings. A stong pipeline will be much stronger. Yes.. still to cheap a selling price. Did expect talks as DRMD crossed 25.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next